Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Share-based Compensation (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Share-based Compensation for 9 consecutive years, with $3485.0 as the latest value for Q1 2025.

  • On a quarterly basis, Share-based Compensation fell 61.96% to $3485.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $12647.0, a 65.49% decrease, with the full-year FY2024 number at $36648.0, changed 0.0% from a year prior.
  • Share-based Compensation was $3485.0 for Q1 2025 at Creative Medical Technology Holdings, down from $9162.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $383612.0 in Q3 2021 to a low of $3485.0 in Q1 2025.
  • A 5-year average of $40703.0 and a median of $9162.0 in 2022 define the central range for Share-based Compensation.
  • Biggest YoY gain for Share-based Compensation was 0.0% in 2023; the steepest drop was 77.85% in 2023.
  • Creative Medical Technology Holdings' Share-based Compensation stood at $383612.0 in 2021, then crashed by 97.61% to $9162.0 in 2022, then changed by 0.0% to $9162.0 in 2023, then changed by 0.0% to $9162.0 in 2024, then plummeted by 61.96% to $3485.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Share-based Compensation are $3485.0 (Q1 2025), $9162.0 (Q4 2024), and $9162.0 (Q3 2024).